Aurora Cannabis Inc (ACB) Q2 2025 Earnings Call Highlights: …
6 days ago · In This Article: ACB. Net Revenue: $81.1 million, a 29% growth. Medical Cannabis Revenue: $61.3 million, 41% increase. International Medical Cannabis Revenue Growth: 93% increase. Adjusted Gross ...
Aurora Cannabis Sees Record Growth in Q2 2025 - Markets Insider
Nov 6, 2024 · Aurora Cannabis reported impressive fiscal 2025 second-quarter results, achieving a record adjusted EBITDA of $10.1 million, marking a 210% increase year-over-year.
Aurora Cannabis Announces Fiscal 2025 Second Quarter Results
Nov 6, 2024 · Medical cannabis net revenue 1 was $61.3 million, a 41% increase from the prior year quarter, delivering 76% of Aurora's Q2 2025 consolidated net revenue 1 and 98% of adjusted gross profit before ...
Aurora Cannabis Reports Strong Q2 Growth Driven By …
Medical cannabis net revenue was CA$61.3 million, a 41% increase from the prior-year quarter, delivering 76% of Aurora’s Q2 2025 consolidated net revenue and 98% of adjusted gross profit before ...
Aurora Cannabis Announces Fiscal 2025 Second Quarter Results
Nov 6, 2024 · Aurora Cannabis Inc (CNW Group/Aurora Cannabis Inc.) "Our strong quarterly results demonstrate Aurora's leadership in global medical cannabis and ability to capitalize on opportunities within rapidly growing markets such as Australia, Germany, Poland, and the UK.International revenue increased 93% to $35 million, exceeding Canadian Medical revenue …
Aurora Cannabis Announces Fiscal 2025 First Quarter Results and ...
EDMONTON, AB, Aug. 7, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada -based global medical cannabis company, today announced...
Aurora Cannabis Announces Fiscal 2024 First Quarter Results, and ...
Aug 10, 2023 · Achieves Quarterly Net Revenue 1 of $75.1 Million; Strong YoY Growth Across All Business Units; Global Medical Cannabis +14%, Consumer Cannabis +5%, Plant Propagation +12%
Aurora Cannabis Announces Fiscal 2024 Third Quarter Results; …
EDMONTON, AB, Feb. 8, 2024 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canada -based leading global medical cannabis company, today announced its...
Aurora Cannabis (ACB) Q4 2024 Earnings Call Transcript - Yahoo Finance
Jun 20, 2024 · Aurora Cannabis(NASDAQ: ACB) Q4 2024 Earnings Call Jun 20, 2024, 8:00 a.m. ET. Contents: Prepared Remarks. Questions and Answers. Call Participants. Prepared Remarks: Operator. Greetings, and...
Aurora Cannabis Posts Fiscal 2025 Second Quarter Results
6 days ago · Medical Cannabis. Medical cannabis net revenue1 was $61.3 million, a 41% increase from the prior year quarter, delivering 76% of Aurora’s Q2 2025 consolidated net revenue1 and 98% of adjusted gross profit before fair value adjustments. The increase in net revenue1 of $17.8 million was primarily due to higher sales to Australia, Germany ...